Rethinking Clinical Trials with Synthetic Control Arms

25 Apr

Written By Alexandra Collingbourne

Alexandra Collingbourne

Verinnogen raises £500k to advance cancer drug development

Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models